-- JPMorgan Chase (JPM), Morgan Stanley (MS), and Danske Bank are working on Leo Pharma's potential initial public offering in Denmark, Bloomberg reported Monday, citing sources familiar with the matter.
Sources told Bloomberg that the IPO could happen this year and Leo Pharma could hire more banks for the sale. Plans remain subject to change as no final decision has been made, according to the report.
Bloomberg said Leo Pharma was valued at about 3 billion euros ($3.51 billion), including debt, in 2021.
JPMorgan Chase, Morgan Stanley, Danske Bank, and Leo Pharma did not immediately respond to' requests for comments.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: $307.98, Change: $-1.89, Percent Change: -0.61%